Article
Vincristine treatment reverses podocyte damage in focal segmental glomerulosclerosis
2024-11-15
Abstract excerpt
<h4>Introduction</h4> Focal segmental glomerulosclerosis (FSGS) is a significant cause of chronic kidney disease and triggered by podocyte damage which can result in cytoskeletal alterations leading to foot process effacement. Vincristine is a chemoprotective drug which alters cytoskeletal microtubules and has been used clinically to reverse FSGS. However, the mechanisms underlying the beneficial effect of vincri...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 829c74b2-6ea1-5d18-acad-5cfd7d4961ea
- DOI
- 10.1101/2024.11.13.623397
